SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells

Yang Cui, Lili Qin, Jing Wu, Xuan Qu, Chen Hou, Wenyan Sun, Shiyong Li, Andrew T M Vaughan, Jian-Jian Li, Jiankang Liu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

SIRT3 is a key NAD<sup>+</sup>-dependent protein deacetylase in the mitochondria of mammalian cells, functioning to prevent cell aging and transformation via regulation of mitochondrial metabolic homeostasis. However, SIRT3 is also found to express in some human tumors; its role in these SIRT3-expressing tumor cells needs to be elucidated. This study demonstrated that the expression of SIRT3 was elevated in a group of gastric cancer cells compared to normal gastric epithelial cells. Although SIRT3 expression levels were increased in the gastric tumor tissues compared to the adjacent non-tumor tissues, SIRT3 positive cancer cells were more frequently detected in the intestinal type gastric cancers than the diffuse type gastric cancers, indicating that SIRT3 is linked with subtypes of gastric cancer. Overexpression of SIRT3 promoted cell proliferation and enhanced ATP generation, glucose uptake, glycogen formation, MnSOD activity and lactate production, which were inhibited by SIRT3 knockdown, indicating that SIRT3 plays a role in reprogramming the bioenergetics in gastric tumor cells. Further analysis revealed that SIRT3 interacted with and deacetylated the lactate dehydrogenase A (LDHA), a key protein in regulating anaerobic glycolysis, enhancing LDHA activity. In consistence, a cluster of glycolysis-associated genes was upregulated in the SIRT3-overexpressing gastric tumor cells. Thus, in addition to the well-documented SIRT3-mediated mitochondrial homeostasis in normal cells, SIRT3 may enhance glycolysis and cell proliferation in SIRT3-expressing cancer cells.

Original languageEnglish (US)
Article numbere0129834
JournalPLoS One
Volume10
Issue number6
DOIs
StatePublished - Jun 29 2015

Fingerprint

stomach neoplasms
glycolysis
Glycolysis
Stomach Neoplasms
Cells
Tumors
Stomach
Neoplasms
Cell proliferation
lactate dehydrogenase
cell proliferation
homeostasis
Homeostasis
Tissue
Cell Proliferation
Mitochondria
Intestinal Neoplasms
cells
neoplasm cells
Cell Aging

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Cui, Y., Qin, L., Wu, J., Qu, X., Hou, C., Sun, W., ... Liu, J. (2015). SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells. PLoS One, 10(6), [e0129834]. https://doi.org/10.1371/journal.pone.0129834

SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells. / Cui, Yang; Qin, Lili; Wu, Jing; Qu, Xuan; Hou, Chen; Sun, Wenyan; Li, Shiyong; Vaughan, Andrew T M; Li, Jian-Jian; Liu, Jiankang.

In: PLoS One, Vol. 10, No. 6, e0129834, 29.06.2015.

Research output: Contribution to journalArticle

Cui, Yang ; Qin, Lili ; Wu, Jing ; Qu, Xuan ; Hou, Chen ; Sun, Wenyan ; Li, Shiyong ; Vaughan, Andrew T M ; Li, Jian-Jian ; Liu, Jiankang. / SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells. In: PLoS One. 2015 ; Vol. 10, No. 6.
@article{07707a31668e4c73bb520979fd19fbc7,
title = "SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells",
abstract = "SIRT3 is a key NAD+-dependent protein deacetylase in the mitochondria of mammalian cells, functioning to prevent cell aging and transformation via regulation of mitochondrial metabolic homeostasis. However, SIRT3 is also found to express in some human tumors; its role in these SIRT3-expressing tumor cells needs to be elucidated. This study demonstrated that the expression of SIRT3 was elevated in a group of gastric cancer cells compared to normal gastric epithelial cells. Although SIRT3 expression levels were increased in the gastric tumor tissues compared to the adjacent non-tumor tissues, SIRT3 positive cancer cells were more frequently detected in the intestinal type gastric cancers than the diffuse type gastric cancers, indicating that SIRT3 is linked with subtypes of gastric cancer. Overexpression of SIRT3 promoted cell proliferation and enhanced ATP generation, glucose uptake, glycogen formation, MnSOD activity and lactate production, which were inhibited by SIRT3 knockdown, indicating that SIRT3 plays a role in reprogramming the bioenergetics in gastric tumor cells. Further analysis revealed that SIRT3 interacted with and deacetylated the lactate dehydrogenase A (LDHA), a key protein in regulating anaerobic glycolysis, enhancing LDHA activity. In consistence, a cluster of glycolysis-associated genes was upregulated in the SIRT3-overexpressing gastric tumor cells. Thus, in addition to the well-documented SIRT3-mediated mitochondrial homeostasis in normal cells, SIRT3 may enhance glycolysis and cell proliferation in SIRT3-expressing cancer cells.",
author = "Yang Cui and Lili Qin and Jing Wu and Xuan Qu and Chen Hou and Wenyan Sun and Shiyong Li and Vaughan, {Andrew T M} and Jian-Jian Li and Jiankang Liu",
year = "2015",
month = "6",
day = "29",
doi = "10.1371/journal.pone.0129834",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - SIRT3 enhances glycolysis and proliferation in SIRT3-expressing gastric cancer cells

AU - Cui, Yang

AU - Qin, Lili

AU - Wu, Jing

AU - Qu, Xuan

AU - Hou, Chen

AU - Sun, Wenyan

AU - Li, Shiyong

AU - Vaughan, Andrew T M

AU - Li, Jian-Jian

AU - Liu, Jiankang

PY - 2015/6/29

Y1 - 2015/6/29

N2 - SIRT3 is a key NAD+-dependent protein deacetylase in the mitochondria of mammalian cells, functioning to prevent cell aging and transformation via regulation of mitochondrial metabolic homeostasis. However, SIRT3 is also found to express in some human tumors; its role in these SIRT3-expressing tumor cells needs to be elucidated. This study demonstrated that the expression of SIRT3 was elevated in a group of gastric cancer cells compared to normal gastric epithelial cells. Although SIRT3 expression levels were increased in the gastric tumor tissues compared to the adjacent non-tumor tissues, SIRT3 positive cancer cells were more frequently detected in the intestinal type gastric cancers than the diffuse type gastric cancers, indicating that SIRT3 is linked with subtypes of gastric cancer. Overexpression of SIRT3 promoted cell proliferation and enhanced ATP generation, glucose uptake, glycogen formation, MnSOD activity and lactate production, which were inhibited by SIRT3 knockdown, indicating that SIRT3 plays a role in reprogramming the bioenergetics in gastric tumor cells. Further analysis revealed that SIRT3 interacted with and deacetylated the lactate dehydrogenase A (LDHA), a key protein in regulating anaerobic glycolysis, enhancing LDHA activity. In consistence, a cluster of glycolysis-associated genes was upregulated in the SIRT3-overexpressing gastric tumor cells. Thus, in addition to the well-documented SIRT3-mediated mitochondrial homeostasis in normal cells, SIRT3 may enhance glycolysis and cell proliferation in SIRT3-expressing cancer cells.

AB - SIRT3 is a key NAD+-dependent protein deacetylase in the mitochondria of mammalian cells, functioning to prevent cell aging and transformation via regulation of mitochondrial metabolic homeostasis. However, SIRT3 is also found to express in some human tumors; its role in these SIRT3-expressing tumor cells needs to be elucidated. This study demonstrated that the expression of SIRT3 was elevated in a group of gastric cancer cells compared to normal gastric epithelial cells. Although SIRT3 expression levels were increased in the gastric tumor tissues compared to the adjacent non-tumor tissues, SIRT3 positive cancer cells were more frequently detected in the intestinal type gastric cancers than the diffuse type gastric cancers, indicating that SIRT3 is linked with subtypes of gastric cancer. Overexpression of SIRT3 promoted cell proliferation and enhanced ATP generation, glucose uptake, glycogen formation, MnSOD activity and lactate production, which were inhibited by SIRT3 knockdown, indicating that SIRT3 plays a role in reprogramming the bioenergetics in gastric tumor cells. Further analysis revealed that SIRT3 interacted with and deacetylated the lactate dehydrogenase A (LDHA), a key protein in regulating anaerobic glycolysis, enhancing LDHA activity. In consistence, a cluster of glycolysis-associated genes was upregulated in the SIRT3-overexpressing gastric tumor cells. Thus, in addition to the well-documented SIRT3-mediated mitochondrial homeostasis in normal cells, SIRT3 may enhance glycolysis and cell proliferation in SIRT3-expressing cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84938578281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938578281&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0129834

DO - 10.1371/journal.pone.0129834

M3 - Article

C2 - 26121691

AN - SCOPUS:84938578281

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e0129834

ER -